Home › BIO-RAD LABORATORIES, INC. › VARIANT nbs
VARIANT nbs
BIO-RAD LABORATORIES, INC. · Model 250-3003 · UDI-DI 00847817008306
1
510(k) clearances
2
Adverse events
10
Recalls
10
Facilities
Description
VARIANT nbs Sickle Cell Program Analytical Cartridge
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2022-04-07 | Bio-Rad Laboratories, Inc. | The problem is with the Bio-Rad VARIANT nbs Sickle Cell Program Resin Update CD-ROM software; Model Number: 250-3020, included in VARIANT nbs Sickle Cell Progam Reorder Pack #250-3 |
| 2020-10-09 | Primus Corporation | The product did not receive pre-market approval or clearance. |
| 2018-11-01 | Clark Laboratories, Inc. (dba,Trinity Biotech USA) | lack of 510K |
| 2018-11-01 | Clark Laboratories, Inc. (dba,Trinity Biotech USA) | lack of 510K |
| 2018-11-01 | Clark Laboratories, Inc. (dba,Trinity Biotech USA) | lack of 510K |
| 2018-11-01 | Clark Laboratories, Inc. (dba,Trinity Biotech USA) | lack of 510K |
| 2018-11-01 | Clark Laboratories, Inc. (dba,Trinity Biotech USA) | lack of 510K |
| 2010-04-22 | Bio-Rad Laboratories Inc | The presence of parameters for Version 40400-S on the labeled VARIANT Sickle Cell Short ROM Card instead of Version 80300-S. |
| 2010-04-14 | Bio-Rad Laboratories Inc | The affected resin Update CD-ROMs cause all user-defined settings in the Setup/Test/Data Setup sub screen and Set/Test/Pattern Setting sub screen to be overwritten when the Update |
| 2004-09-14 | PerkinElmer LAS Inc | The product insert for the test kits is incorrect with regard to the acceptable storage temperature for the Agarose IEF gel component. The kit and IEF gel labels indicate the corr |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.
